Resumo

CHAVEZ PARDO, Iris; VARONA LINARES, Leidy de; COELLAR TORRES, Olga L.  e  GONZALEZ VARONA, Doris. Results of the use of the intravitreous triamcinolone in patients with rubeosis iridis. AMC [online]. 2015, vol.19, n.5, pp. 431-440. ISSN 1025-0255.

Background: rubeosis iridis is generally associated to different diseases that produce lack of oxygen in the retina. It is the most frequent and early complication of many vascular diseases of the posterior segment that causes irreversible loss of vision if it is not early diagnosed and treated. Objective: to describe the behavior of rubeosis iridis after the treatment with intravitreous triamcinolone. Method: a descriptive, longitudinal study was conducted in patients with rubeosis iridis who came to the retina consultation of Carlos J. Finlay Ophthalmology Center from June 2013 to June 2014. The universe of the study was composed of 25 patients and the non-probabilistic sample by 30 eyes that matched the inclusion criteria. A form was applied to collect the data. The results were related to the following variables: ocular tension, symptoms, diseases that cause rubeosis iridis and rubeosis degrees. Results: ocular tension stabilized with the treatment applied. The most frequent symptom was pain. Proliferative diabetic retinopathy was the most frequent disease in the 40 % of the patients, followed by thrombosis of the central retinal vein. More than the half of the patients improved their condition, some of them with a complete regression. Conclusions: intraocular tension improved after the treatment with intravitreous triamcinolone. Symptoms disappeared in more than the half of the patients. Proliferative diabetic retinopathy was the most frequent disease that caused rubeosis iridis. This sign disappeared in more than the half of the patients after the treatment.

Palavras-chave : IRIS DISEASES; TRIAMCINOLONE [therapeutic use]; DIABETIC ANGIOPATHIES; ADULT; EPIDEMIOLOGY, DESCRIPTIVE.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )